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The muscle nicotinic acetylcholine receptor is a large, allo-
steric, ligand-gated ion channel with the subunit composition
2. Althoughmuch is now known about the structure of the
binding site, relatively little is understood about how the bind-
ing event is communicated to the channel gate, causing the pore
to open. Here we identify a key hydrogen bond near the binding
site that is involved in the gating pathway. Using mutant cycle
analysis with the novel unnatural residue -hydroxyserine, we
find that the backbone N-H of Ser-191 in loop C makes a
hydrogen bond to an anionic side chain of the complementary
subunit upon agonist binding. However, the anionic partner is
not the glutamate predicted by the crystal structures of the
homologous acetylcholine-binding protein. Instead, the hydro-
gen-bonding partner is the extensively researched aspartate
Asp-174/Asp-180, which had originally been identified as a
key binding residue for cationic agonists.
The Cys loop family of ligand-gated ion channels is involved
in mediating fast synaptic transmission throughout the central
and peripheral nervous systems (1–3). These neuroreceptors
are among themolecules of learning,memory, and sensory per-
ception, and they are implicated in numerous neurological dis-
orders, including Alzheimer disease, Parkinson disease, and
schizophrenia. The muscle nicotinic acetylcholine receptor
(nAChR)5 is arguably the best-studied member of the Cys loop
family. This heteropentameric receptor is composed of homol-
ogous but functionally distinct subunits arranged symmetri-
cally around a central ion-conducting pore with the stoichiom-
etry 2. The agonist binding sites are located at the
interfaces between the  and  subunits. The binding of two
agonist molecules induces a conformational change that leads
to the opening of the ion channel.
It is nowwidely appreciated that a tryptophan residue (Trp-
149) plays a key role in neurotransmitter binding by forming a
cation- interaction with the quaternary ammonium group of
acetylcholine (4), a result supported by structural data. How-
ever, many other important residues in the immediate vicinity
of the binding site have been identified. In a classic experiment
on the Torpedo nAChR (a close homologue of the muscle sub-
type), Czajkowski and Karlin (5) concluded that a key aspartate
(Asp-174/Asp-180) from the complementary binding sub-
unit could come within 9 Å of the agonist binding site. Muta-
tion of this residue severely impacted receptor function, leading
to a proposal that the negative charge of this aspartate inter-
acted with the positive charge of the agonist (6, 7). Subse-
quently, however, both the crystal structure of acetylcholine-
binding protein (AChBP, a soluble protein homologous to the
extracellular domain of the nAChR) (8) and the 4 Å cryo-elec-
tron microscopy structure of Torpedo nAChR (9, 10) showed
that this residue is positioned quite far from the agonist binding
site (Fig. 1). Single-channel studies suggest that this residue is
primarily important for ligand-induced channel gating rather
than agonist binding (11, 12).
Asp-174/Asp-180 is part of loop F, the most remote of the
six loops originally proposed by Changeux and co-workers (1)
to contribute to the agonist binding site. In the carbamylcho-
line-bound AChBP structure (13), a different F loop anionic
residue, Glu-176/Glu-182 (AChBP Glu-163), is positioned
near loop C of the agonist binding site (Fig. 1). Specifically,
Glu-176/Glu-182 is within hydrogen-bonding distance of
the backbone N-H at Ser-191, which is located on the C loop
between the aromatic binding box residue Tyr-190 and the
vicinal disulfide formed by Cys-192 and Cys-193. Loop F is
generally disordered in the AChBP and nAChR structures, and
hydrogen-deuterium exchange mass spectrometry on AChBP
reveals that loop F and loop C are the most conformationally
dynamic segments of the protein (14). It is generally accepted
that agonist binding draws loopC inward, capping the aromatic
binding pocket (13, 15). In contrast, crystal structures of
AChBP with antagonists bound reveal that loop C pulled away
from the agonist binding site (15). Distinctions between antag-
onist- and agonist-induced motion have also been observed in
loop F (16). As such, many investigators favor a gating model
involving a contraction of the agonist binding site around an
agonist molecule that is largely mediated by movements in
loops C and F, although little is known about the nature of the
specific interactions involved in this systolic motion.
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In the present work, we evaluate several anionic residues in
loop F and potential interactions with loop C. Using a combi-
nation of natural and unnatural mutagenesis, we find that,
indeed, the backbone N-H of Ser-191 does make a hydrogen
bond to a loop F residue. However, the partner is not the gluta-
mate seen in theAChBP crystal structure. Instead, the aspartate
(Asp-174/Asp-180) originally identified by Czajkowski and
Karlin (5) is the hydrogen-bonding partner.
EXPERIMENTAL PROCEDURES
Preparation of Unnatural Amino and Hydroxy Acids—All
chemical reactions were performed under argon using solvent-
column dry solvents (17). Flasks and vials were oven-dried at
122 °C and cooled in a desiccator box containing anhydrous
calcium sulfate. Silica chromatography was carried out in
accordance with the methods of Still et al. (18). The prepara-
tions of nitrohomoalanine (Nha), 2-amino-4-ketopentanoic
acid (Akp), and -hydroxyalanine (Aah) have been described
previously (19–21).
Synthesis of 2,3-Dihydroxypropionate (-Hydroxyserine,
Sah)-tRNA—Glycerate calcium salt dihydrate (286 mg, 2.0
mmol) were measured into a 100-ml round-bottomed flask.
Methanol (40 ml) and toluene (10 ml) were added, followed by
concentrated hydrochloric acid (1 ml, 12 mmol). The mixture
was stirred under reflux for 6 h, at which point the solvent was
removed in vacuo. This crude residue was then dissolved in
dimethylfomamide (6 ml) in a 2-dram vial. tert-Butyldimeth-
ylsilyl chloride (906 mg, 6 mmol) and imidazole (544 mg, 8
mmol) were then added, and the reaction was stirred at room
temperature for 12 h, at which point the reaction was concen-
trated in vacuo to 1 ml, and dichloromethane (10 ml) was
added. The precipitate was removed by filtration, and the fil-
trate was reduced in vacuo and purified by flash chromatogra-
phy on silica (5% ethyl acetate in hexanes) to yield 421 mg (60%
over two steps) of 2,3-di-(tert-butyldimethylsilyl)glycerate
methyl ester. 1H NMR (300 MHz, CDCl3)  4.27 (dd, 1H, J 
5.2, 6.2 Hz), 3.80 (dd, 1H, JAB 9.9 Hz, JAX 5.2 Hz), 3.73 (dd,
1H, JAB 9.9Hz, JAX 6.6Hz), 3.70 (s, 3H), 0.88 (s, 9H), 0.85 (s,
9H), 0.07 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H). 13CNMR
(75 MHz, CDCl3)  172.71, 74.21, 66.16, 51.99, 26.04, 25.94,
18.57, 18.52,4.86,4.87,5.16,5.25. Low resolution mass
spectrometry (ES) calculated for C16H36NaO4Si2 ([MNa])
371.2, found 371.1.
2,3-di-tert-(Butyldimethylsilyl)glycerate methyl ester (100
mg, 0.29 mmol) was measured into a 2-dram vial. Diethyl ether
(3 ml) was added to dissolve the starting material, followed by
potassium trimethylsilanolate (22) (40.7 mg, 0.29 mmol). After
18 h, the potassium salt was isolated by filtration, washed with
2  1 ml ether, and dried in vacuo. The solid was then resus-
pended in chloroacetonitrile (3 ml) and allowed to stir at room
temperature for 6 h. The reaction was then filtered through a
plug of silica to yield the pure product as a colorless liquid: 66.7
mg (62% over two steps) of 2,3-di-tert-(butyldimethylsilyl)glyc-
erate cyanomethyl ester. 1H NMR (300 MHz, CDCl3)  4.75 (s,
2H), 4.35 (t, 1H, J 5.4Hz), 3.81 (d, 2H, J 5.4Hz), 0.90 (s, 9H),
0.87 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H).
13C NMR (75 MHz, CDCl3)  170.82, 114.24, 73.78, 65.92,
48.62, 26.01, 25.87, 18.48, 4.86, 4.90, 5.21, 5.24. High
resolution mass spectrometry (FAB) calculated for
C17H36NO4Si2 ([MH]) 374.2183, found 374.2181. The
transesterification and deprotection of 2,3-di-tert-butyldim-
ethylsilylglycerate cyanomethyl ester were performed accord-
ing to published protocols to yield Sah-tRNA (23).
Side Chain and Backbone Mutagenesis—Conventional
mutagenesis and unnatural mutagenesis, with the site of inter-
estmutated to either an amber stop codonor a four-base frame-
shift codon (at Ser-191), were achieved by a standard Strat-
agene QuikChange protocol. Sequencing through both strands
confirmed the presence of the desiredmutation.Mousemuscle
embryonic nAChR in the pAMV vector was used. All themuta-
tions were made in the presence of a background transmem-
branemutation (L9S) that lowers whole-cell EC50 (24, 25). In
addition, the-subunits contain a hemagglutinin epitope in the
M3-M4 cytoplasmic loop for Western blot studies. Control
experiments show that this epitope does not detectably alter
EC50. mRNA was prepared by in vitro runoff transcription
using the Ambion (Austin, TX) T7 mMessage mMachine kit.
For conventional mutants, a total of 2.0–4.0 ng of mRNA was
injected in a ratio of 2:1:1:1 of :::. For suppression with
unnatural amino and hydroxy acids, a total of 4.0 ng of mRNA
was injected in an::: subunit ratio of 10:1:1:1. Typically, 25
ng of tRNAwas injected per oocyte along withmRNA in a ratio
of 1:1 with a total volume of 50 nl/cell. As a negative control for
suppression, truncated 74-nucleotide tRNAor truncated tRNA
ligated to deoxycytosine adenosinewas co-injectedwithmRNA
in the same manner as fully charged tRNA. Data from experi-
ments where currents from these negative controls were
greater than 10% of the experimental were excluded. Frame-
shift suppression at Ser-191 was used for simultaneous incor-
poration of two unnatural residues (26).
Electrophysiology—The function of mutant receptors was
evaluated using two-electrode voltage clamp (see supplemental
materials). Stage V–VI oocytes of Xenopus laevis were
employed. Oocyte recordings were made 12–48 h after injec-
FIGURE 1. Structure of AChBPwith carbamylcholine bound (ProteinData
Bank: 1UV6); numbering as in nAChR. Residues considered here are shown
in space filling. The C loop (cyan) and F loop (orange) are highlighted. In this
structure, the C and F loops have closed around the bound agonist (agonist
not shown). A carboxylate oxygen (red) ofGlu-176 iswithin hydrogen-bond-
ing distance of the backbone NH (blue) of Ser-191.
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tion in two-electrode voltage clamp mode using the Opus-
Xpress 6000A instrument (Axon Instruments, UnionCity, CA).
Oocytes were superfused with a Ca2-free ND96 solution at
flow rates of 1ml/min before application, 4ml/min during drug
application, and 3 ml/min during wash. Holding potential was
60 mV. Data were sampled at 125 Hz and filtered at 50 Hz.
Drug applications were 15 s in duration. Acetylcholine chloride
was purchased from Sigma-Aldrich/RBI. Solutions ranging
from 0.01 to 5000Mwere prepared in Ca2-free ND96 from a
1M stock solution.Dose-response datawere obtained for amin-
imumof eight concentrations of agonists and for aminimumof
five cells. Dose-response relations were fitted to the Hill equa-
tion to determine EC50 and Hill coefficient values. The dose-
response relations of individual oocytes were examined and
used to determine outliers. The reported EC50 values are from
the curve fit of the averaged data.
RESULTS
A Backbone Mutation at Ser-191 Has a Large Impact on
Receptor Function—In the process of probing the backbone
flexibility surrounding the nAChR binding box, we mutated
Ser-191 to Sah. This produces an ester backbone linkage at
this position, while preserving the side chain. Along with
increasing backbone flexibility, this mutation removes the
hydrogen bond-donatingN-Hgroup and replaces it with a non-
hydrogen bond-donating O (Figs. 2 and 3).We have performed
similar backbonemutations at several positions throughout the
nAChR, and typically, the consequences are not dramatic (19,
27). However, at Ser-191, this subtle mutation leads to a
40-fold increase in EC50 (Table 1 and Fig. 2B). We also made
alanine and Aahmutations at this site. The side chainmutation
alone had minimal impact on receptor function, producing no
shift in EC50. However, receptor function of the S191Aah
mutant was dramatically impaired relative to S191Ala, con-
firming that the backbone, and not the side chain, atSer-191 is
important for receptor function.
Evaluating Anionic Residues on Loop F—To evaluate the
potential hydrogen bond from Ser-191 to Glu-176/Glu-
182, wemade several mutations at this glutamate. Surprisingly,
all mutations have minimal impact, suggesting no critical role
for this residue. Another nearby loop F glutamate residue,
FIGURE 2. A, natural and unnatural residues used in this study. B, EC50 ratios (mutant/wild type) for natural and unnatural substitutions at four sites in the
extracellular domain. For glutamine and Nha, EC50 ratios were calculated with reference to glutamate instead of wild type (aspartate).
FIGURE 3.Mutant cycle analysis for a backbone mutation at Ser-191
and a side chain mutation at Asp-174/Asp-180 with the equation
for calculating the coupling energy. Note that introducing the -hy-
droxy acid Sah removes the backbone NH proposed to hydrogen bond to
Asp-174/Asp-180.
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Glu-163169/Glu-163175, was also evaluated. Again, no sig-
nificant impact was seen.
In sharp contrast, even the subtlest mutations at Asp-174/
Asp-180 produce large effects upon receptor function, a result
that others have also seen (5, 6, 28, 29). We first studied aspar-
agine, glutamate, and glutamine mutations at this site. The
D174E/D180Emutant exhibits amodest3-fold decrease in
EC50. However, the D174N/D180N and D174Q/D180Q
mutants produce substantial (100-fold) changes to the EC50
(Fig. 2B and Table 1).
Fundamentally, the results of these conventional mutations
strongly implicate the side chain of Asp-174/Asp-180 in an
electrostatic interaction, such as an ion pair or hydrogen bond.
However, changing the side chain functionality from a carbox-
ylate to an amide not only neutralizes the charge on the side
chain, it also desymmetrizes it and introduces a potential
hydrogen bond donor. To better understand the role of Asp-
174/Asp-180, we incorporated two unnatural amino acids.
Nha is an analogue of glutamate that contains a nitro (NO2)
group, which is isosteric and isoelectronic to a carboxylate, but
it has no charge and is a much weaker hydrogen bond acceptor
(Fig. 2A).6 Incorporation of Nha at Asp-174/Asp-180 yields a
slightly less dramatic effect than the D174N/D180N and
D174Q/D180Q mutants, producing a 24-fold shift in EC50
relative to D174E/D180E (Fig. 2B). Thus, charge neutraliza-
tion at this site significantly affects receptor function but can-
not fully account for the EC50 shift seen in the D174N/
D180N and D174Q/D180Q mutants.
The second unnatural amino acid analogue incorporated at
Asp-174/Asp-180 was Akp. Akp is isoelectronic to Asp but
possesses a methyl ketone functionality in place of the carbox-
ylate (Fig. 2A). As such, Akp is a desymmetrized analogue of
Asp, similar to Asn, but it has different electrostatic properties
(less polar, weaker hydrogen bond acceptor, and cannot donate
a hydrogen bond). When Akp is incorporated at Asp-174/
Asp-180, its effect upon receptor function is roughly as dele-
terious as the Asn mutation (Fig. 2B). Mutations at individual
binding sites (D174N and D180N) showed substan-
tial (50-fold) and approximately equivalent increases in
whole cell EC50 (supplemental Table 1).
Mutant Cycle Analysis Reveals a Strong Interaction between the
Ser-191 Backbone and the Side Chain of Asp-174/Asp-180—
Mutant cycle analysis was performed between several of the side
chain mutations at Asp-174/Asp-180 and the S191Sah
mutation (Figs. 3 and 4). Briefly, mutant cycle analysis is used to
determine the pairwise interaction energy between two resi-
dues in a protein using the equation given in Fig. 3. If the two
residues do not interact, the change in free energy for the simul-
taneous mutation of both residues should simply be the sum of
the free energy of each of the individual mutations. However,
for residues that interact, the change in free energy for the dou-
ble mutation will be non-additive. EC50-based mutant cycle
analysis has been used to investigate interactions in Cys loop
receptors by other researchers (30–32). Further discussion can
be found in the supplemental materials.
Lengthening the side chain (D174E/D180E) has no impact
on the interaction between these two residues (G  0.12
kcal/mol). In contrast, mutant cycle analysis between D174N/
D180N and S191Sah indicates a large energetic coupling
(G 2.1 kcal/mol). A smaller but still quite significant effect
6 Although nitroalanine, the analogue of aspartate, would be ideal, it is not
chemically compatible with the nonsense suppression methodology.
Given that the mutation D174E/D180E produces a very modest EC50
shift and that D174N/D180N and D174Q/D180Q show similar effects
on receptor function, the comparison of Nha with Glu can be considered
meaningful.
FIGURE 4. Coupling energies between various side chain mutants in the
complementary binding subunit and the backbone mutation at Ser-
191 (S191Sah).ForglutamineandNha, freeenergycalculationsweremade
with reference to glutamate instead of wild type (aspartate).
TABLE 1
EC50 values the standard error of the mean for mutations made in this study
In all cases, the -subunit contains an L9S mutation.
Mutant EC50 Double mutant EC50 G
M M kcal/mol
 1.2	 0.04
S191 Sah 50	 2.3
E176AE182A 1.2	 0.08 S191Sah/E176A/E182A 32	 1.7 0.27	 0.06
E176QE182Q 2.0	 0.10 S191Sah/E176Q/E182Q 51	 2.4 0.29	 0.03
E168QE175Q 1.2	 0.02 S191Sah/E168Q/E175Q 37	 1.2 0.18	 0.05
D174ED180E 0.3	 0.01 S191Sah/D174E/D180E 15	 0.90 0.12	 0.05
D174QD180Q 59	 2.0 S191Sah/D174Q/D180Q 96	 5.2 1.9	 0.05
D174NhaD180Nha 7.9	 0.40 S191Sah/D174Nha/D180Nha 31	 1.9 1.4	 0.05
D174ND180N 160	 2.7 S191Sah/D174N/D180N 190	 12 2.1	 0.05
D174AkpD180Akp 220	 19 S191Sah/D174Akp/D180Akp 190	 12 2.3	 0.15
S191 Ala 1.1	 0.06 S191Ala/D174N/D180N 230	 8.0 0.25	 0.04
S191 Aah 63	 2.4 S191Aah/D174N/D180N 130	 7.6 2.5	 0.04
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is seen for the mutant cycle analysis between D174Nha/
D180Nha and S191Sah (G 1.4 kcal/mol). Mutant cycle
analyses of D174N/D180N with S191A and S191Aah fur-
ther support the conclusion that the interaction between these
residues involves the backbone of Ser-191 and not the side
chain (S191Ala: G  0.25; S191Aah: G  2.3 kcal/
mol). Not surprisingly, comparablemutant cycle analyses of the
two glutamates of loop F, Glu-176/Glu-182 and Glu-
163169/Glu-163175, with S191Sah showed no significant
coupling.
DISCUSSION
The AChBP crystal structures transformed the study of
nAChRs by providing high resolution structural data about the
ligand binding domain of these proteins. In addition to refining
our existing structural knowledge of the receptor, obtained
from decades of careful biochemical research, it served as a
valuable starting point for new structure-function studies on
the receptor. However, AChBP is not a ligand-gated ion chan-
nel and, in fact, shares less than 25% homology with its nearest
Cys loop relative, the 7 nAChR (8). As such, some fundamen-
tal structural differencesmust exist between AChBP and actual
Cys loop receptors, particularly pertaining to residues involved
in mediating communication between the binding site and the
ion channel pore.
Arguably the biggest discrepancy between the AChBP struc-
tures and prior biochemical studies of the nAChR concerns the
loop F residueAsp-174/Asp-180.A remarkable cross-linking
study in the Torpedo nAChR indicated that this residue can
comewithin 9Å of the vicinal disulfide on theC loop, located at
the heart of the agonist binding site (5). However, in AChBP,
the residue that aligns with Asp-174/Asp-180 is not at all
near the agonist binding site. In addition, the cryo-electron
microscopy structure of the Torpedo nAChR, which is believed
to be in the desensitized or closed state, places this residue
tucked deeply inside a -sheet-lined hydrophobic pocket, over
15 Å from loop C (9, 10).
Although Asp-174/Asp-180 is remote to the agonist bind-
ing site in AChBP, another loop F anionic residue, Glu-
176Glu-182, appears to make a hydrogen bond to a backbone
N-H that is integral to the aromatic box of the agonist binding
site when the agonist carbamylcholine is bound. Using non-
sense suppression methodology, we have been able to specifi-
cally remove the backbone N-H in question by replacing Ser-
191 with its -hydroxy analogue. Consistent with the AChBP
images, this subtle structural change has a large effect on recep-
tor function, suggesting that a hydrogen bond to this moiety is
important. However, consistent with prior mutational analyses
(6, 7, 28), we find that Glu-176/Glu-182 does not play a large
role in receptor function. This suggests that AChBP does not
provide an accurate model of the muscle nAChR in this region.
Given that the sequence alignment in this region shows a num-
ber of insertions in nAChR relative to AChBP, combined with
the fact that the F loop is believed to be involved in gating the
nAChR (AChBP does not gate), it is not surprising that AChBP
would be an unreliable model here.
Our results indicate that the hydrogen-bonding partner for
the backboneN-H of Ser-191 in the nAChR is instead the side
chain of Asp-174/Asp-180. Based on the available structural
and functional data, we suggest that this hydrogen bond exists
in the open state only (11, 28, 29). As others have seen, a number
of mutations of this side chain profoundly affect receptor func-
tion. Here we employ several relatively subtle mutations. The
fact that substantial functional consequences are seen suggests
a precise structural role for this side chain in at least one state
crucial for activating the channel. Furthermore, allmutations at
Asp-174/Asp-180 that significantly impact function also
show strong coupling to the S191Sah backbone mutation via
mutant cycle analysis. The nature of the coupling is as one
would expect from the hydrogen-bonding model. Mutation at
either site has a strong effect; however, once the S191Sah
mutation is introduced, removing any possible hydrogen-
bonding interaction, mutations at Asp-174/Asp-180 have a
much smaller impact. Interestingly, no specific role for the side
chain of Ser-191 is found as the S191A mutant gives essen-
tially wild-type behavior.7 However, when the alanine side
chain is combined with the -hydroxy backbone mutation, the
same coupling to Asp-174/Asp-180 is observed.
We propose that themovement of loop F of the complemen-
tary subunit from a position remote to the agonist binding site
to one of close proximity to loop C of the principal subunit is a
key early structural change associated with nAChR gating.
Driving this structural reorganization is the formation of a
hydrogen bond between the side chain of Asp-174/Asp-180
and the backbone N-H of Ser-191. In the closed state of the
wild-type receptor, Ser-191 and the C loop project out into
solution, away from the bulk of the receptor, whereas Asp-
174/Asp-180 of the F loop projects deep within a hydrophobic
cavity. Although the energetic desolvation penalty of burying a
charged residue within a hydrophobic cavity is significant,8 it
alone is apparently not sufficient to overcome other structural
elements that bias this conformation of the F loop. However,
agonist binding induces a centripetal movement of the C loop,
bringing the backbone N-H of Ser-191 in closer proximity to
the F loop. This structural change makes possible a hydrogen
bond between Asp-174/Asp-180 and the C loop backbone.
We hypothesize that the formation of this hydrogen bond,
along with the energetic solvation benefit of moving Asp-174/
Asp-180 into an aqueous environment, provides sufficient
driving force to move Asp-174/Asp-180 out of its pocket,
inducing a movement of the F loop toward the C loop.9 This
structural rearrangement of loop F contributes to the gating
pathway. Using rate-equilibrium free energy relationships,
Auerbach and co-workers (34) have also concluded that Asp-
174/Asp-180 moves early in the gating process.
Our results provide an explanation for the cross-linking
studies of Czajkowski andKarlin (5), and they are not in conflict
with available structural information. The cryo-electron
microscopy images of the Torpedo receptor show greater than
20 Å separation between Ser-191 and Asp-174/Asp-180 in
7 In AChBP structures, theSer-191 side chain alsomakes hydrogen bonds to
Glu-176/Glu-182.
8 Based on the hydrophobicity constant,, the expected desolvation penalty
for an aspartic acid residue would be on the order of 1 kcal/mol (33).
9 The possibility of a salt bridge forming here can be eliminated, given that
there are no basic residues in the C loop or in its vicinity.
Intersubunit Hydrogen Bond in the Nicotinic Receptor
35642 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 51•DECEMBER 19, 2008
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Decem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
the closed state. Still, the distance of less than 9 Å that is sug-
gested by the cross-linking studies is plausible, provided that
the residues are free to move closer, as occurs in our model of
channel gating. A comparison of AChBP structures with and
without agonist bound likewise shows that motions of loops C
and F are the dominant structural rearrangements that occur
when agonist binds. The fact that the hydrogen bond acceptor
in loop F differs between AChBP and nAChR is not surprising,
given that loop F is strongly implicated in nAChR gating and
AChBP did not evolve to have a gating function.
This model is also consistent with the 174/180 mutants
described here. Lengthening the side chain of this key F loop
residue (D174E/D180E) effects a modest improvement in
receptor function, either because the longer side chain can
more easily reach its Ser-191 hydrogen-bonding partner or
because it fits more poorly in the hydrophobic pocket, destabi-
lizing the closed state. Any mutation that eliminates side chain
charge has a significant impact on function, which is expected,
given that these mutant side chains are poorer hydrogen bond
acceptors and that they experience a much lower energetic sol-
vation benefit upon moving from the hydrophobic pocket into
an aqueous environment.
In conclusion, mutant cycle analysis involving a novel back-
bone mutant has identified an important interaction between
an F loop residue that has long been thought to contribute to
receptor function and the peptide backbone of loop C. The
hydrogen bond between the side chain of Asp-174/Asp-180
and the backbone of Ser-191 likely forms upon agonist bind-
ing and is part of the agonist-induced conformational changes
that lead to channel opening. Along with contributing new
insights into the gating pathway of the nAChR, our results rec-
oncile a long-standing discrepancy between early biochemical
studies of the receptor and structural models from the AChBP
systems.
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